{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:12:23Z","timestamp":1786975943576,"version":"build-2736575974"},"publisher-location":"Chichester, UK","reference-count":89,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd010782","type":"reference-entry","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T03:34:51Z","timestamp":1381894491000},"source":"Crossref","is-referenced-by-count":43,"title":["Anticonvulsants for fibromyalgia"],"prefix":"10.1002","author":[{"given":"Nurcan","family":"\u00dc\u00e7eyler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Walitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"H\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,10,16]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD010782-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/art.22457","article-title":"Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"56","author":"Arnold","year":"2007","journal-title":"Arthritis and Rheumatism"},{"issue":"9","key":"10.1002\/14651858.CD010782-BIB2|cit2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpain.2008.03.013","article-title":"A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia","volume":"9","author":"Arnold","year":"2008","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD010782-BIB3|cit3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.20983","article-title":"Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial","volume":"52","author":"Crofford","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD010782-BIB4|cit4","first-page":"502","article-title":"A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia","volume":"35","author":"Mease","year":"2008","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010782-BIB5|cit5","doi-asserted-by":"crossref","first-page":"R217","DOI":"10.1186\/ar4056","article-title":"A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia","volume":"14","author":"Ohta","year":"2012","journal-title":"Arthritis Research and Therapy"},{"issue":"12","key":"10.1002\/14651858.CD010782-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3899\/jrheum.110569","article-title":"An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia","volume":"38","author":"Pauer","year":"2011","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010782-BIB7|cit7","unstructured":"Rowbotham M Levetiracetam for treatment of pain associated with fibromyalgia. First received on 15 November 2005; last updated on 12 April 2011 www.clinicaltrials.gov\/ct2\/show\/NCT00254657"},{"key":"10.1002\/14651858.CD010782-BIB8|cit8","unstructured":"UCB Assessing efficacy and safety of lacosamide compared to placebo in reducing signs and symptoms of fibromyalgia syndrome. First received on 9 November 2006; last updated 30 August 2011 clinicaltrials.gov\/ct2\/show\/NCT00401830"},{"issue":"3","key":"10.1002\/14651858.CD010782-BIB9|cit9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pain.2008.02.027","article-title":"Fibromyalgia Relapse Evaluation and Efficacy for Durability Of Meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin","volume":"136","author":"Crofford","year":"2008","journal-title":"Pain"},{"key":"10.1002\/14651858.CD010782-BIB10|cit10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/acr.21595","article-title":"Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study","volume":"64","author":"Roth","year":"2012","journal-title":"Arthritis Care and Research (Hoboken)"},{"key":"10.1002\/14651858.CD010782-BIB11|cit11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0033-3182(10)70741-6","article-title":"Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia","volume":"51","author":"Arnold","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD010782-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.clinthera.2012.03.003","article-title":"Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia","volume":"34","author":"Arnold","year":"2012","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD010782-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"European Journal of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD010782-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1002\/14651858.CD010782-BIB15|cit15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2474-8-27","article-title":"An internet survey of 2,596 people with fibromyalgia","volume":"8","author":"Bennett","year":"2007","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"10","key":"10.1002\/14651858.CD010782-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3899\/jrheum.100104","article-title":"Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome - a systematic review and metaanalysis of randomized controlled trials","volume":"37","author":"Bernardy","year":"2010","journal-title":"Journal of Rheumatology"},{"issue":"9","key":"10.1002\/14651858.CD010782-BIB17|cit17","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009796.pub2","article-title":"Cognitive behavioural therapies for fibromyalgia","author":"Bernardy","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010782-BIB18|cit18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/14737175.9.1.33","article-title":"Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures","volume":"9","author":"Beydoun","year":"2009","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"5","key":"10.1002\/14651858.CD010782-BIB19|cit19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009485.pub2","article-title":"Phenytoin for neuropathic pain and fibromyalgia in adults","author":"Birse","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010782-BIB20|cit20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1002\/14651858.CD010782-BIB21|cit21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/JPR.S7884","article-title":"Pregabalin for the management of fibromyalgia syndrome","volume":"22","author":"Boomershine","year":"2010","journal-title":"Journal of Pain Research"},{"key":"10.1002\/14651858.CD010782-BIB22|cit22","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.09.008","article-title":"Pathophysiology of fibromyalgia","volume":"122","author":"Bradley","year":"2009","journal-title":"American Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010782-BIB23|cit23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.semarthrit.2008.12.003","article-title":"Prevalence of fibromyalgia: a survey in five European countries","volume":"39","author":"Branco","year":"2010","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD010782-BIB24|cit24","first-page":"16","article-title":"Drugs to treat fibromyalgia - the transatlantic difference","volume":"11","author":"Briley","year":"2010","journal-title":"Current Opinion in Investigational Drugs"},{"key":"10.1002\/14651858.CD010782-BIB25|cit25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/ar2720","article-title":"Developments in the scientific and clinical understanding of fibromyalgia","volume":"11","author":"Buskila","year":"2009","journal-title":"Arthritis Research Therapy"},{"key":"10.1002\/14651858.CD010782-BIB26|cit26","unstructured":"Centers for Disease Control and Prevention 2012 Fibromyalgia www.cdc.gov\/arthritis\/basics\/fibromyalgia.htm"},{"key":"10.1002\/14651858.CD010782-BIB27|cit27","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"5","key":"10.1002\/14651858.CD010782-BIB28|cit28","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009486.pub2","article-title":"Clonazepam for neuropathic pain and fibromyalgia in adults","author":"Corrigan","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010782-BIB29|cit29","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007070.pub2","article-title":"Acupuncture for treating fibromyalgia","author":"Deare","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010782-BIB30|cit30","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008244.pub2","article-title":"Milnacipran for neuropathic pain and fibromyalgia in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010782-BIB31|cit31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tips.2006.12.006","article-title":"Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission","volume":"28","author":"Dooley","year":"2007","journal-title":"Trends in Pharmacological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD010782-BIB32|cit32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pain.2009.08.019","article-title":"Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations","volume":"146","author":"Dworkin","year":"2009","journal-title":"Pain"},{"issue":"12","key":"10.1002\/14651858.CD010782-BIB33|cit33","article-title":"Psychological therapies for the management of chronic and recurrent pain in children and adolescents","author":"Eccleston","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010782-BIB34|cit34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010782-BIB35|cit35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00482-012-1167-z","article-title":"Fibromyalgia syndrome: general principles and coordination of clinical care and patient education","volume":"26","author":"Eich","year":"2012","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD010782-BIB36|cit36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00482-012-1169-x","article-title":"Fibromyalgia syndrome: definition, classification, clinical diagnosis and prognosis","volume":"26","author":"Eich","year":"2012","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD010782-BIB37|cit37","unstructured":"European Medicines Agency Refusal assessment report for Lyrica, 2009 www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000546\/WC500076177.pdf"},{"key":"10.1002\/14651858.CD010782-BIB38|cit38","unstructured":"FDA FDA approves first drug for treating fibromyalgia, 2007 www.fda.gov\/newsevents\/newsroom\/pressAnnouncements\/2007\/ucm108936.htm"},{"key":"10.1002\/14651858.CD010782-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3899\/jrheum.130127","article-title":"Canadian Pain Society and Canadian Rheumatology Association recommendations for rational care of persons with fibromyalgia. A summary report","volume":"40","author":"Fitzcharles","year":"2013","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010782-BIB40|cit40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004850-200501000-00010","article-title":"Imputing response rates from means and standard deviations in meta-analyses","volume":"20","author":"Furukawa","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD010782-BIB41|cit41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD010782-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00228-012-1464-6","article-title":"Pregabalin abuse and dependence in Germany: results from a database query","volume":"69","author":"Gahr","year":"2013","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD010782-BIB43|cit43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.berh.2011.02.003","article-title":"Neuroimaging of fibromyalgia","volume":"25","author":"Gracely","year":"2011","journal-title":"Best Practice and Research Clinical Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD010782-BIB44|cit44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD010782-BIB45|cit45","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009318.pub2","article-title":"Lacosamide for neuropathic pain and fibromyalgia in adults","author":"Hearn","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7414","key":"10.1002\/14651858.CD010782-BIB46|cit46","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010782-BIB47|cit47","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD010782-BIB48|cit48","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00482-007-0602-z","article-title":"What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association","volume":"22","author":"H\u00e4user","year":"2008","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD010782-BIB49|cit49","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/AJP.0b013e3181d92a6c","article-title":"Diagnosis of fibromyalgia syndrome - a comparison of Association of the Medical Scientific Societies in Germany, survey, and American College of Rheumatology criteria","volume":"26","author":"H\u00e4user","year":"2010","journal-title":"Clinical Journal of Pain"},{"key":"10.1002\/14651858.CD010782-BIB50|cit50","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/ar3002","article-title":"Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials","volume":"12","author":"H\u00e4user","year":"2010","journal-title":"Arthritis Research Therapy"},{"issue":"8","key":"10.1002\/14651858.CD010782-BIB51|cit51","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/acr.20328","article-title":"Emotional, physical and sexual abuse in fibromyalgia syndrome - a systematic review with meta-analysis","volume":"63","author":"H\u00e4user","year":"2011","journal-title":"Arthritis Care and Research (Hoboken)"},{"key":"10.1002\/14651858.CD010782-BIB52|cit52","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00482-012-1161-5","article-title":"German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies [in German]","volume":"26","author":"H\u00e4user","year":"2012","journal-title":"Schmerz"},{"issue":"6 Suppl 74","key":"10.1002\/14651858.CD010782-BIB53|cit53","first-page":"78","article-title":"Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for\u00a0fibromyalgia\u00a0syndrome treatment: systematic review and meta-analysis","volume":"30","author":"H\u00e4user","year":"2012","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD010782-BIB54|cit54","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","author":"H\u00e4user","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010782-BIB55|cit55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00482-010-0937-8","article-title":"Influence of depression on fibromyalgia: a systematic review","volume":"24","author":"Lange","year":"2010","journal-title":"Schmerz"},{"issue":"1","key":"10.1002\/14651858.CD010782-BIB56|cit56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II","volume":"58","author":"Lawrence","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1002\/14651858.CD010782-BIB57|cit57","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00482-011-1079-3","article-title":"Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009","volume":"25","author":"Marschall","year":"2011","journal-title":"Schmerz"},{"issue":"10","key":"10.1002\/14651858.CD010782-BIB58|cit58","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3899\/jrheum.090367","article-title":"Fibromyalgia syndrome module at OMERACT 9: domain construct","volume":"36","author":"Mease","year":"2009","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD010782-BIB59|cit59","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD010782-BIB60|cit60","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD010782-BIB61|cit61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pain.2009.08.007","article-title":"Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD010782-BIB62|cit62","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD010782-BIB63|cit63","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010782-BIB64|cit64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"key":"10.1002\/14651858.CD010782-BIB65|cit65","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0031-1271689","article-title":"Pregabalin-induced suicidal ideations","volume":"44","author":"Mutschler","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1002\/14651858.CD010782-BIB66|cit66","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006192","article-title":"Anti-depressants and centrally active agents for fibromyalgia syndrome","author":"Nishishinya","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD010782-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00005650-200110000-00002","article-title":"Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life","volume":"39","author":"Norman","year":"2001","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD010782-BIB68|cit68","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.seizure.2006.02.004","article-title":"Pregabalin-associated acute psychosis and epileptiform EEG-changes","volume":"15","author":"Olaizola","year":"2006","journal-title":"Seizure"},{"key":"10.1002\/14651858.CD010782-BIB69|cit69","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2459\/JCM.0b013e3282fb7629","article-title":"Possible heart failure exacerbation associated with pregabalin: case discussion and literature review","volume":"9","author":"Page","year":"2008","journal-title":"Journal of Cardiovascular Medicine (Hagerstown)"},{"key":"10.1002\/14651858.CD010782-BIB70|cit70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.berh.2011.02.005","article-title":"Central pain mechanisms in chronic pain states - maybe it is all in their head","volume":"25","author":"Phillips","year":"2011","journal-title":"Best Practice and Research Clinical Rheumatology"},{"key":"10.1002\/14651858.CD010782-BIB71|cit71","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"4","key":"10.1002\/14651858.CD010782-BIB72|cit72","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1086\/650004","article-title":"Comparative efficacy versus effectiveness of initial antiretroviral therapy in clinical trials versus routine care","volume":"15","author":"Routman","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD010782-BIB73|cit73","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004844.pub3","article-title":"Antipsychotics for acute and chronic pain in adults","author":"Seidel","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010782-BIB74|cit74","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00482-012-1174-0","article-title":"Etiology and pathophysiology of fibromyalgia syndrome","volume":"26","author":"Sommer","year":"2012","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD010782-BIB75|cit75","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/rheumatology\/kep432","article-title":"Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports","volume":"49","author":"Straube","year":"2010","journal-title":"Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD010782-BIB76|cit76","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009807","article-title":"Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome","author":"Tort","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010782-BIB77|cit77","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2710.2009.01144.x","article-title":"Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis","volume":"35","author":"Tzellos","year":"2010","journal-title":"Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD010782-BIB78|cit78","first-page":"467","article-title":"Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures","volume":"5","author":"Ulloa","year":"2009","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"6","key":"10.1002\/14651858.CD010782-BIB79|cit79","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD010782-BIB80|cit80","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008314.pub2","article-title":"Topiramate for neuropathic pain and fibromyalgia in adults","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010782-BIB81|cit81","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/11535250-000000000-00000","article-title":"Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study","volume":"9","author":"Winkelmann","year":"2011","journal-title":"Applied Health Economics and Health Policy"},{"issue":"12","key":"10.1002\/14651858.CD010782-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/art.1780331217","article-title":"The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis and Rheumatism"},{"issue":"9","key":"10.1002\/14651858.CD010782-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/art.1780400904","article-title":"A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia","volume":"40","author":"Wolfe","year":"1997","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD010782-BIB84|cit84","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1002\/14651858.CD010782-BIB85|cit85","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pain.2010.09.027","article-title":"The development of fibromyalgia - I: examination of rates and predictors in patients with rheumatoid arthritis (RA)","volume":"152","author":"Wolfe","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD010782-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD010782-BIB87|cit87","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/acr.21931","article-title":"Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population","volume":"65","author":"Wolfe","year":"2013","journal-title":"Arthritis Care and Research (Hoboken)"},{"key":"10.1002\/14651858.CD010782-BIB88|cit88","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/j.1532-2149.2012.00234.x","article-title":"Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia","volume":"17","author":"Wolfe","year":"2013","journal-title":"European Journal Pain"},{"key":"10.1002\/14651858.CD010782-BIB89|cit89","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/brain\/awt053","article-title":"Small fibre pathology in patients with fibromyalgia syndrome","volume":"136","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Brain"}],"updated-by":[{"DOI":"10.1002\/14651858.cd010782.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T00:00:00Z","timestamp":1507507200000},"record-id":"30914"},{"DOI":"10.1002\/14651858.cd010782.pub2","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T00:00:00Z","timestamp":1507507200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:48:28Z","timestamp":1628534908000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD010782"}},"subtitle":[],"editor":[{"given":"Winfried","family":"H\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,16]]},"references-count":89,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010782","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718145505.793486890","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2013,10,16]]}}}